Boston Trust Walden’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$609K Buy
3,122
+5
+0.2% +$994 ﹤0.01% 318
2026
Q2
$530K Hold
3,117
– – ﹤0.01% 332
2026
Q1
$527K Sell
3,117
-300
-9% -$57.5K ﹤0.01% 323
2025
Q4
$643K Hold
3,417
– – ﹤0.01% 309
2025
Q3
$701K Sell
3,417
-61
-2% -$13K 0.01% 305
2025
Q2
$775K Buy
3,478
+2,014
+138% +$434K 0.01% 294
2025
Q1
$301K Hold
1,464
– – ﹤0.01% 346
2024
Q4
$267K Sell
1,464
-16
-1% -$3.36K ﹤0.01% 354
2024
Q3
$305K Buy
1,480
+16
+1% +$3.09K ﹤0.01% 345
2024
Q2
$256K Hold
1,464
– – ﹤0.01% 355
2024
Q1
$251K Hold
1,464
– – ﹤0.01% 354
2023
Q4
$221K Buy
+1,464
New +$196K ﹤0.01% 357

Other funds holding CTAS

Boston Trust Walden's CTAS Position: Q3 2026 in Review

Boston Trust Walden increased its Cintas (CTAS) stake by 0.16% in Q3 2026, buying an estimated $994 and bringing the position to 3,122 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Boston Trust Walden first reported a position in CTAS in Q4 2023 and has held it in 12 quarters since. The position peaked at $775K in Q2 2025. 961 funds tracked by Wall St. Rank hold CTAS as of Q3 2026.

  • Boston Trust Walden held 3,122 shares of Cintas worth $609K as of Q3 2026.
  • Boston Trust Walden bought 5 Cintas shares in Q3 2026, an estimated $994.
  • Cintas made up ﹤0.01% of Boston Trust Walden's portfolio in Q3 2026, its #318 holding.
  • Boston Trust Walden first reported a position in Cintas in Q4 2023 and has held it in 12 quarters since.
  • Boston Trust Walden's Cintas position peaked at $775K in Q2 2025.
  • 961 funds tracked by Wall St. Rank held Cintas as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.